Vendor, Tarrytown, NY
Regeneron Pharmaceuticals Inc.
UEI N3F9MH7E6HD6, CAGE 544P9
6 awards and -$53,744,108 obligated between January 2, 2024 and September 25, 2026, 83% under full and open competition, against 167.5 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Department of Veterans Affairs | $0 |
| Office of Assistant Secretary for Preparedness and Response | -$53,744,108 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $0 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | -$53,744,108 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 5 |
| Not Competed | 1 |
| Definitive Contract | 3 |
Hear when Regeneron Pharmaceuticals Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Regeneron Pharmaceuticals Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- -$332,474,556
- Soonest
- September 25, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling pharmaceutical preparation manufacturing to Department of Veterans Affairs, by dollars.
| Mckesson CorporationIrving, TX | $31,461,755,412 |
| Exelan Pharmaceuticals Inc.Boca Raton, FL | $175,193,835 |
| Progenics Pharmaceuticals Inc.North Billerica, MA | $98,046,501 |
| Cardinal Health 414, LLCDublin, OH | $75,939,729 |
| Novartis Pharmaceuticals CorporationEast Hanover, NJ | $56,726,790 |
| Sofie Co.Dulles, VA | $25,337,798 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- J&A to extend Period or Performance for procurement of Inmazeb
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
JustificationNAICS 541714Tarrytown, NYJOFOC-REG-1Awarded to Regeneron Pharmaceuticals Inc.
Posted Oct 10
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201700016CDefinitive Contract, December 6, 2024, Full and Open Competition, 2 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Mod to Revise the Contract Sections: Article B.2.1., Article C.1., Article F.4, , Article G.4. and the Statement of Work.NAICS 541711, PSC AN13 | $280,503,480 |
| 36E79721A0023August 29, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option Year 3NAICS 325412, PSC 6505 | $0 |
| 36F79721D0169January 2, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Permanent Price DecreaseNAICS 325412, PSC 6505 | $0 |
| HHSO100201600023CDefinitive Contract, March 19, 2026, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Regeneron Anti-Mers Antibody Therapeutics Program DevelopmentNAICS 541711, PSC AN11 | -$337,504 |
| HHSO100201500013CJuly 23, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | De-Obligate Fiscal Year 2024 Canceling Funds.NAICS 541711, PSC AN13 | -$1,435,528 |
| HHSO100201700020CDefinitive Contract, December 5, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Modification to Revise the Joint Oversight Committee Members and Extend the Period of Performance for Clin 0001 to Sept 25, 2027.NAICS 541711, PSC AN13 | -$332,474,556 |
- Places of performance
- New York
- Product and service codes
- 6505 Drugs and BiologicalsAN11 Health R&D Services; Health Care Services; Basic ResearchAN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 43 across 6 awards